Recent editions
- February 2015
Mathematicians are developing a blood flow model for metastasis. - January 2015
René Bernards on discovering effective drug combinations. - December 2014
Research on the high rate of burnout among young oncologists. - November 2014
Carl June on the efficacy of CAR-T cells in treating leukaemia. - October 2014
News from ESMO 2014 with Solange Peters and Alexander Eggermont. - September 2014
Discussing how healthcare systems can meet the needs of cancer survivors. - July/August 2014
Sophie Postel-Vinay on new recommendations for phase 1 trials. - June 2014
Hans Clevers on important research into stem cells in normal gut tissue. - May 2014
Carolyn Taylor and Paul McGale find evidence to clarify guidelines for radiotherapy after mastectomy. - April 2014
Richard Sullivan and Ajay Aggarwal on how physicians can tackle the issue of affordability in cancer care. - March 2014
The 1st EORTC Cancer Survivorship Summit addressed the practical problems faced by cancer patients. - February 2014
Charles Swanton on a study that maps genetic changes in cancers over time.
EJC News Focus – May 2013
Highlights of 2nd ESTRO Forum
By the year 2020, it is estimated that for every tumour, data will be available on 10,000 markers related to survival. How are clinicians to make sense – and practical use – of it all?
According to ESTRO President, Vincenzo Valentini, a good way to start might be to involve radiation oncologists who already have expertise in complex imaging and dose-planning models. The decision models of the future will become even more sophisticated, he says, able to codify quality of life so that the needs of individual patients can be met.
This was just one of the themes of the 2nd ESTRO Forum (Geneva; 19-23 April 2013). Others included the combination of radiation therapy and drugs; and the use of a single shot of radiotherapy to control pain. Here Vincenzo Valentini discusses the highlights of the forum with Helen Saul.